Cenra Inc. (TPE:3716)
Taiwan · Delayed Price · Currency is TWD 33.85
+0.25 (0.74%)
At close: Mar 6, 2026
Cenra Market Cap
Cenra has a market cap or net worth of 4.95 billion as of March 6, 2026. Its market cap has decreased by -12.72% in one year.
Market Cap
4.95B
Enterprise Value
7.33B
Revenue
8.68B
Ranking
n/a
PE Ratio
12.76
Stock Price
33.85
Market Cap Chart
Since September 2, 2024, Cenra's market cap has decreased from 6.21B to 4.95B, a decrease of -20.24%. That is a compound annual growth rate of -13.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.95B | 1.35% |
| Dec 31, 2025 | 4.88B | -12.15% |
| Dec 31, 2024 | 5.56B | -10.42% |
| Sep 2, 2024 | 6.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 259.07B |
| Caliway Biopharmaceuticals | 216.22B |
| Heron Neutron Medical | 73.71B |
| Lotus Pharmaceutical | 70.48B |
| Locus Cell | 5.30B |
| Panion & Bf Biotech | 5.25B |
| OBI Pharma | 5.23B |
| Pharmosa Biopharm | 5.23B |